tiprankstipranks
Trending News
More News >
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT

Alaunos Therapeutics (TCRT) Price & Analysis

Compare
683 Followers

TCRT Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

17.53%3.60%<0.01%77.62%
17.53% Insiders
<0.01% Other Institutional Investors
77.62% Public Companies and
Individual Investors

TCRT FAQ

What was Alaunos Therapeutics’s price range in the past 12 months?
Alaunos Therapeutics lowest stock price was $1.31 and its highest was $7.40 in the past 12 months.
    What is Alaunos Therapeutics’s market cap?
    Alaunos Therapeutics’s market cap is $7.39M.
      When is Alaunos Therapeutics’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Alaunos Therapeutics’s earnings last quarter?
      Alaunos Therapeutics released its earnings results on Aug 08, 2024. The company reported -$0.705 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.705.
        Is Alaunos Therapeutics overvalued?
        According to Wall Street analysts Alaunos Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Alaunos Therapeutics pay dividends?
          Alaunos Therapeutics does not currently pay dividends.
          What is Alaunos Therapeutics’s EPS estimate?
          Alaunos Therapeutics’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Alaunos Therapeutics have?
          Alaunos Therapeutics has 1,639,521 shares outstanding.
            What happened to Alaunos Therapeutics’s price movement after its last earnings report?
            Alaunos Therapeutics reported an EPS of -$0.705 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.481%.
              Which hedge fund is a major shareholder of Alaunos Therapeutics?
              Currently, no hedge funds are holding shares in TCRT

              Company Description

              Alaunos Therapeutics

              Alaunos Therapeutics (TCRT) is a biotechnology company focused on the development and commercialization of innovative, cell-based cancer immunotherapies. Operating within the healthcare and biotechnology sectors, the company is committed to advancing its proprietary T-cell receptor (TCR) therapy platform. This platform is designed to harness the power of the body's immune system to target and destroy cancer cells, offering potential treatments for a variety of solid tumor cancers.
              Similar Stocks
              Company
              Price & Change
              Follow
              Theriva Biologics
              Sonnet BioTherapeutics Holdings
              Oragenics
              Windtree Therapeutics
              Xenetic Biosciences
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis